Latest News

Filters

Filter by tags: South Korea Canada Germany Russia European Union Clear all tag filters

5 news articles found


Japan, the UK, Canada, the US and France have agreed to co-operate to reduce dependence on Russia as a supplier of nuclear materials and technology. Their statement was issued at the Nuclear Energy Forum being held in Japan’s Sapporo alongside the meeting of Group of Seven (G7) ministers on climate, energy and environment. It was published on the UK government website.

Date: Thursday, 20 April 2023
Original article: neimagazine.com/news/newsfive-g7-nations-aim-to-cut-dependence-on-russian-nuclear-technology-10770200

Group of Seven (G7) energy and environment ministers, following a two-day meeting in the northern Japanese city of Sapporo, issued a 36-page communique laying out their commitments ahead of a G7 summit in Hiroshima in May. The detailed statement covered sections on environment, climate and energy. It reaffirmed a commitment to accelerating the clean energy transition to net-zero greenhouse gas emissions by 2050. “We call on and will work with other countries to end new unabated coal-fired power generation projects globally as soon as possible to accelerate the clean energy transition in a just manner,” the statement says, stipulating that countries should rely on “predominantly” clean energy by 2035.

Date: Wednesday, 19 April 2023
Original article: neimagazine.com/news/newsg7-ministers-reaffirm-net-zero-targets-condemn-russia-and-offer-only-qualified-support-for-nuclear-10770194

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

An IAEA proposal to establish a nuclear safety and security protection zone around Ukraine’s Zaporizhzhia Nuclear Power Plant (ZNPP) is receiving strong international support and detailed talks have now begun with Ukraine and Russia aimed at agreeing and implementing it as soon as possible, IAEA Director General Rafael Mariano Grossi has revealed after a series of high-level meetings in New York.

Date: Thursday, 29 September 2022
Original article: neimagazine.com/news/newsiaea-proposal-for-zaporozhzhia-safety-and-security-protection-zone-wins-support-10041911

Nuclear energy has faced serious challenges in recent years because of several factors: competition from low gas prices, subsidised renewables and slow growth in electricity demand in certain markets. But because of several powerful forces we are seeing signs that this year nuclear energy will come roaring back, writes Jarret Adams.

Date: Wednesday, 07 March 2018
Original article: world-nuclear-news.org/Articles/Five-reasons-nuclear-energy-will-rebound-in-2018